These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 4976352)

  • 81. [Prevention of recurrence of superficial tumors of the bladder with intravesical epirubicin].
    Lancina Martín JA; García Pérez M; Arrabal Martín M; Vilches Cocovi E
    Actas Urol Esp; 1990; 14(2):112-4. PubMed ID: 2378265
    [TBL] [Abstract][Full Text] [Related]  

  • 82. [Intravesical instillation in the treatment of superficial tumors of the bladder].
    Chopin DK
    Prog Urol; 1998 Apr; 8(2):268-73. PubMed ID: 9615941
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Intravesical chemoprophylaxis of superficial transitional cell carcinoma of the bladder. When should the drug be given?
    Bouffioux C
    Prog Clin Biol Res; 1985; 185B():47-55. PubMed ID: 4034591
    [No Abstract]   [Full Text] [Related]  

  • 84. Intravesical treatment with thiotepa: an update review.
    Fosså SD
    Prog Clin Biol Res; 1984; 162B():163-8. PubMed ID: 6438640
    [No Abstract]   [Full Text] [Related]  

  • 85. The management of superficial bladder cancer.
    Soloway MS
    Cancer; 1980 Apr; 45(7 Suppl):1856-65. PubMed ID: 6768441
    [No Abstract]   [Full Text] [Related]  

  • 86. The effects of intravesical instillation of Thio-Tepa on the recurrence rate of bladder tumors.
    Asahi T; Matsumura Y; Tanahashi T; Yoshimoto J; Kaneshige T; Fujita Y; Ohmori H
    Acta Med Okayama; 1980 Feb; 34(1):43-9. PubMed ID: 6446839
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Bladder cancer chemotherapy studies supported by the National Bladder Cancer Project.
    Friedell GH
    Cancer Chemother Pharmacol; 1983; 11 Suppl():S13-5. PubMed ID: 6416697
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Rationale for intensive intravesical chemotherapy for superficial bladder cancer.
    Soloway MS
    J Urol; 1980 Apr; 123(4):461-6. PubMed ID: 6767860
    [No Abstract]   [Full Text] [Related]  

  • 89. Prognostic factors for recurrence and followup policies in the treatment of superficial bladder cancer: report from the British Medical Research Council Subgroup on Superficial Bladder Cancer (Urological Cancer Working Party).
    Parmar MK; Freedman LS; Hargreave TB; Tolley DA
    J Urol; 1989 Aug; 142(2 Pt 1):284-8. PubMed ID: 2501516
    [TBL] [Abstract][Full Text] [Related]  

  • 90. The FISH test for the diagnosis, surveillance, and prognosis of transitional cell carcinoma of the bladder.
    Haddad FS
    J Med Liban; 2008; 56(4):230-2. PubMed ID: 19115598
    [TBL] [Abstract][Full Text] [Related]  

  • 91. [Spontaneously cured pancytopenia due to intravesical thio-tepa, apropos of one case].
    Archimbaud JP; Calcat P; Martel JP
    J Urol Nephrol (Paris); 1973 Dec; 79(12 Pt 2):487-8. PubMed ID: 4216648
    [No Abstract]   [Full Text] [Related]  

  • 92. [Intravesical application of thio-tepa for preventing postoperative recurrence of bladder carcinoma].
    Zhang SX; Deng XZ; Tang XD
    Zhonghua Wai Ke Za Zhi; 1986 Aug; 24(8):486-7, 510. PubMed ID: 3102180
    [No Abstract]   [Full Text] [Related]  

  • 93. [Control of bladder tumors. Transabdominal ultrasonic scanning versus cystoscopy].
    Graversen HP; Sørensen LH
    Ugeskr Laeger; 1987 Nov; 149(48):3253-5. PubMed ID: 3324434
    [No Abstract]   [Full Text] [Related]  

  • 94. Prostatic recurrences in the management of superficial bladder tumors.
    Lockhart JL; Chaikin L; Bondhus MJ; Politano VA
    J Urol; 1983 Aug; 130(2):256-7. PubMed ID: 6410083
    [TBL] [Abstract][Full Text] [Related]  

  • 95. [Cytostatic topical therapy and prevention of recurrence in bladder papillomatosis].
    Lunglmayr G
    Wien Klin Wochenschr; 1971 Jul; 83(27):526-8. PubMed ID: 5001284
    [No Abstract]   [Full Text] [Related]  

  • 96. Absorption studies on intraluminal thio-tepa for topical cytostatic treatment of low-stage bladder tumors.
    Lunglmayr G; Czech K
    J Urol; 1971 Jul; 106(1):72-4. PubMed ID: 4998357
    [No Abstract]   [Full Text] [Related]  

  • 97. Bladder hyperthermia in the treatment of vesical papillomatosis.
    Lunglmayr G; Czech K; Zekert F; Kellner G
    Int Urol Nephrol; 1973 Jan; 5(1):75-84. PubMed ID: 4203803
    [No Abstract]   [Full Text] [Related]  

  • 98. Rethinking the secondary prevention of superficial bladder cancer: is there a role for retinoids?
    Nutting C; Huddart RA
    BJU Int; 2000 Jun; 85(9):1023-6. PubMed ID: 10848688
    [No Abstract]   [Full Text] [Related]  

  • 99. Instillation of thio-tepa (Tifosyl) in vesical papillomatosis.
    Edsmyr F; Boman J
    Acta Radiol Ther Phys Biol; 1970 Oct; 9(5):395-400. PubMed ID: 4990891
    [No Abstract]   [Full Text] [Related]  

  • 100. Comment on "Does the probiotic L. casei help prevent recurrence after transurethral resection for superficial bladder cancer?".
    Naito S
    Nat Clin Pract Urol; 2009 Mar; 6(3):E5. PubMed ID: 19265853
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.